This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.


Pilot and Feasibility Grant (alpha-1 antitrypsin deficiency)


The Pilot and Feasibility Grant funded by the Alpha-1 Foundation support researchers working on alpha-1 antitrypsin (AAT) expression, and the pathogenesis/management of AAT deficiency. The proposed project should generate new hypotheses and/or new methods in research areas relevant to AAT deficiency. Applicants may apply for up to 75,000 USD over 1 year (no indirect costs). This is an annual award and the next letters of intent are due September 30, 2022 and invited full applications are due February 17, 2023.

Recipient qualification: 

Be the first to know

Sign-up for Personalized Grant alerts

Sign-up for the
monthly research
funding newsletter

You can unsubscribe at any time.